• Pomalidomide (CC-4047): Applied Workflows in Hematological R

  2026-05-29

  Pomalidomide (CC-4047) empowers hematological malignancy research by enabling precise immunomodulation and robust tumor microenvironment assays. This guide details advanced experimental workflows, protocol enhancements, and troubleshooting strategies that maximize reproducibility and insight across multiple myeloma and erythroid differentiation studies.

• Gastrin I Peptide in Human GI Models: Protocols & Innovation

  2026-05-28

  Harness the precision of human Gastrin I peptide for advanced gastric acid secretion pathway research with hiPSC-derived organoids. This guide delivers actionable protocols, troubleshooting insights, and benchmarks APExBIO's product for reproducibility and translational impact.

• Carfilzomib Enhances 125I Radiation-Induced Cell Death in ES

  2026-05-28

  This study demonstrates that carfilzomib amplifies iodine-125 seed radiation's anti-tumor effects in esophageal squamous cell carcinoma by intensifying endoplasmic reticulum stress. The work elucidates how combined treatment triggers multiple cell death pathways—including apoptosis, paraptosis, and ferroptosis—offering a mechanistically robust approach to overcoming radioresistance.

• UBR1 and UBR2: Central ER Stress Sensors and PQC Regulators

  2026-05-27

  This article examines the recent discovery that the E3 ligases UBR1 and UBR2 function as central ER stress sensors in mammals, revealing a new layer of complexity in protein quality control (PQC). The findings highlight the adaptive stabilization of these N-recognins under ER stress and their role in protecting cells from stress-induced apoptosis, with implications for research on ER stress in cancer and neurodegeneration.

• HyperScribe SP6 High Yield RNA Synthesis Kit: Precision in R

  2026-05-27

  The HyperScribe SP6 High Yield RNA Synthesis Kit empowers researchers to efficiently generate high-yield, modification-ready RNA for advanced applications, including radiolabeled probe synthesis, RNA vaccine research, and RNA interference. Its robust design supports streamlined workflows, exceptional reproducibility, and rapid troubleshooting—making it a standout solution for demanding experimental needs.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor An

  2026-05-26

  Wang et al. (2018) systematically delineated the entry mechanism of genotype III grass carp reovirus (GCRV104), demonstrating that viral internalization occurs via clathrin-mediated, pH-dependent endocytosis. Their pharmacological inhibitor profiling clarified the limited role of actin cytoskeleton disruption in GCRV104 entry, informing both virology research and cytoskeletal assay design.

• Capecitabine in Patient-Derived Tumor Models: Precision and

  2026-05-26

  Explore Capecitabine's mechanism and impact in patient-derived assembloid models, revealing how its tumor-selective activation and apoptosis induction via Fas-dependent pathway inform preclinical oncology research and tumor-targeted drug delivery strategies.

• Gastrin I: Precision Tools for Human Gastric Acid Pathway Re

  2026-05-25

  Human Gastrin I peptide from APExBIO unlocks robust, reproducible modeling of gastric acid secretion in advanced in vitro systems—especially hiPSC-derived intestinal organoids. This guide details optimized workflows, troubleshooting strategies, and key innovations driving next-generation gastrointestinal physiology studies.

• Brefeldin A in Cancer and Endothelial Research: Applied Work

  2026-05-25

  Brefeldin A (BFA) redefines ER stress and apoptosis assays by enabling precise dissection of protein trafficking and cell death pathways. This guide delivers actionable workflows, troubleshooting strategies, and translational insights, highlighting APExBIO’s trusted supply and the latest biomarker-informed research.

• HyperScribe™ T7 High Yield RNA Synthesis Kit: Mechanisms & B

  2026-05-24

  The HyperScribe™ T7 High Yield RNA Synthesis Kit enables rapid, high-yield in vitro RNA synthesis using T7 RNA polymerase. This kit supports versatile applications, including capped and biotinylated RNA production for advanced research. Its quantitative performance and workflow integration are supported by published benchmarks and rigorous peer-reviewed evidence.

• Polyether Ionophore Toxicity: Mechanisms and Implications fo

  2026-05-23

  This review provides a comprehensive analysis of the clinical and molecular mechanisms underlying polyether ionophore toxicity in animals, with a focus on Salinomycin and related compounds. The findings highlight the dual significance of these agents—as both toxicants in veterinary contexts and potential anti-cancer candidates—by elucidating their structure, ion transport mechanisms, and cellular effects.

• ERAD-Hijacking ERADECs: A Platform for TM Protein Degradatio

  2026-05-22

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a novel small-molecule platform that co-opts the ER-associated degradation (ERAD) pathway to selectively degrade transmembrane (TM) proteins. This innovation overcomes longstanding barriers in targeted protein degradation, enabling highly efficient elimination of membrane targets and broadening the scope for drug discovery and membrane protein research.

• GSK J4 HCl: JMJD3 Inhibitor Workflows in Epigenetic Research

  2026-05-22

  GSK J4 HCl stands out as a high-performance JMJD3 inhibitor, propelling research into histone methylation, immune modulation, and cancer biology. This article demystifies advanced workflows and troubleshooting strategies, transforming GSK J4 HCl from a chemical tool into a reliable engine for translational epigenetics.

• Screening MMV Compounds Reveals Antifungal Activity Against

  2026-05-21

  This study systematically screened the MMV Pandemic Response Box to identify compounds with in vitro activity against multidrug-resistant (MDR) bacterial and fungal clinical isolates, including Candida species. The findings highlight new antifungal candidates, demonstrate robust methodology for resistance screening, and inform future translational research on Candida infection management.

• GPER1 as a Chemopreventive Target in Prostate Cancer Progres

  2026-05-21

  This study establishes G-protein coupled estrogen receptor 1 (GPER1) as a critical suppressor of prostate cancer (PCa) progression, particularly at the high-grade prostatic intraepithelial neoplasia (HGPIN) stage. By integrating human samples, animal models, and mechanistic in vitro assays, the authors demonstrate that GPER1 activation halts tumorigenic transition, highlighting its therapeutic relevance.

14757 records 2/984 page Previous Next 12345 下5页 Last page